Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 901–1,000 of 1,004
Huda, N., Hosen, M. I., Yasmin, T., Sarkar, P. K., Hasan, A., & Nabi, A. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198507 · Cited by 34
Srivastava, R., Rolyan, H., Xie, Y., Li, N., Bhat, N., Hong, L., Esteghamat, F., Adeniran, A., Geirsson, A., Zhang, J., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311830 · Cited by 43
“This notion, however, is in sharp contrast with the previous findings that Wnt/TCF7L2 promotes cell cycle activation and proliferation during early embryogenesis and in adult stem cells.(12,14,15) Additionally, whether the disease-associated TCF7L2 common variants cause gain or loss of function has remained controvers…”
Genetics of Obesity and Type 2 Diabetes in African Americans
McCormack, S. E., & Grant, S. F. A. (2013) · Journal of Obesity · doi:10.1155/2013/396416 · Cited by 38
“Variation within intron 3 of the transcription factor 7-like 2 (TCF7L2) gene [70] is very strongly associated with the development of T2D.”
BackgroundSelf-citationRotger, M., Gsponer, T., Martínez, R., Taffé, P., Elzi, L., Vernazza, P., Cavassini, M. L., Bernasconi, E., Hirschel, B. J., Furrer, H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656630 · Cited by 33
“known DM loci identified in multiple GWAS: FTO (rs8050136), KCNJ11 (rs5219), TCF7L2 (rs7903146), and PPARG (rs1801282) [13–16, 19, 20, 28, 29].”
Guewo‐Fokeng, M., Sobngwi, E., Atogho‐Tiedeu, B., Donfack, O. S., Noubiap, J. J., Ngwa, E. N., Mato, E. P. M., Pokam, P. F., Djahmeni, E. N., Djokam-Dadjeu, R., et al. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0148-z · Cited by 34
“studies, several susceptibility loci for T2DM have been identified [5], including the transcription factor 7-like 2 (TCF7L2) which is involved in insulin secretion [6,7].”
BackgroundQi, L., & Liang, J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346cb6 · Cited by 31
Bridging epigenomics and complex disease: the basics
Teperino, R., Lempradl, A. M., & Pospisilik, J. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1299-z · Cited by 38
“More than a decade of GWAS has uncovered more than 800 single nucleotide polymorphisms (SNPs) associated with disease predisposition, development and progression.”
InfluentialGenetic susceptibility of diabetic retinopathy
Patel, S., Chen, H., Tinkham, N. H., & Zhang, K. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0046-6 · Cited by 36
Reduction in Tcf7l2 Expression Decreases Diabetic Susceptibility in Mice
Yang, H., Li, Q., Lee, J., & Shu, Y. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4568 · Cited by 33
“larly, single nucleotide polymorphisms (SNPs) in human TCF7L2 gene are known to be strongly associated with an increased risk of type 2 diabetes through the extensive genome-wide association studies in multiple ethnic populations [11-13].”
BackgroundPearson, E. R. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0028-3 · Cited by 35
Investigation of genes important in neurodevelopment disorders in adult human brain
Maussion, G., Diallo, A., Gigek, C. O., Chen, E., Crapper, L., Théroux, J., Chen, G. G., Vasuta, C., & Ernst, C. (2015) · Human Genetics · doi:10.1007/s00439-015-1584-z · Cited by 35
Körner, A., Berndt, J., Stümvoll, M., Kieß, W., & Kovacs, P. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2514 · Cited by 31
Kaput, J., & Dawson, K. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.02.033 · Cited by 36
Lee, D. S., An, T. H., Kim, H.-M., Jung, E., Kim, G., Oh, S. Y., Kim, J. S., Chun, H. J., Jung, J., Lee, E., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05878-8 · Cited by 33
“According to genome-wide association studies in humans, Tcf7l2 is one of the strongest risk factors associated with type 2 diabetes [9, 10].”
BackgroundEwens, K. G., Jones, M. R., Ankener, W., Stewart, D. R., Urbanek, M., Dunaif, A., Legro, R. S., Chua, A., Azziz, R., Spielman, R. S., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.050 · Cited by 30
Predicting tissue specific transcription factor binding sites
Zhong, S., He, X., & Bar‐Joseph, Z. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-796 · Cited by 30
“38) was linked to type 2 diabetes risk in previous studies using SNP data [44], but the mechanism for its involvement was unclear.”
Type 2 Diabetes in Childhood: Clinical Characteristics and Role of β-Cell Autoimmunity
Badaru, A., & Pihoker, C. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0247-2 · Cited by 34
Rutter, G. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12579 · Cited by 34
Bailey, K. A., Savic, D., Zielinski, M. C., Park, S. Y., Wang, L., Witkowski, P., Brady, M., Hara, M., Bell, G. I., & Nóbrega, M. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu577 · Cited by 30
TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling
Liu, D., Nguyen, T. T. L., Gao, H., Huang, H., Kim, D. C., Sharp, B., Ye, Z., Lee, J., Coombes, B. J., Ördög, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01274-z · Cited by 33
The Genetics of Diabetes: What We Can Learn from Drosophila
Liguori, F., Mascolo, E., & Vernì, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011295 · Cited by 36
“However, in few cases, including SLC30A8 and TCF7L2, the causative link between T2D and SNPs has been elucidated [35–37].”
BackgroundInfluentialThe Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs
van Leeuwen, N., Swen, J. J., Guchelaar, H., & Hart, L. M. ‘. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0076-3 · Cited by 32
“Transcription factor 7-like 2 (TCF7L2) is one of the strongest and most replicated loci for susceptibility to T2DM [44].”
BackgroundHoffmann, M. M., Werner, C. M., Böhm, M., Laufs, U., & Winkler, K. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0155-2 · Cited by 32
Genetics of type 2 diabetes mellitus and obesity—a review
Jafar‐Mohammadi, B., & McCarthy, M. I. (2008) · Annals of Medicine · doi:10.1080/07853890701670421 · Cited by 35
“Even before the current frenzy of GWA activity, this kind of biology-agnostic approach claimed what may turn out to be its largest single success—the identification of T2D susceptibility variants within the TCF7L2 gene (43).”
BackgroundGenome-wide association studies: the good, the bad and the ugly
Frayling, T. M. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-428 · Cited by 42
Yan, Y., North, K. E., Ballantyne, C. M., Brancati, F. L., Chambless, L. E., Franceschini, N., HEISS, G. M., Köttgen, A., Pankow, J. S., Selvin, E., et al. (2008) · Diabetes · doi:10.2337/db08-0569 · Cited by 38
“Although the TCF7L2 effect is consistently observed across ethnically diverse populations (3,4), studies conducted in African Americans have been of small sample size and results have been inconsistent (4–6,8,9).”
BackgroundHussain, H., Ramachandran, V., Ravi, S., Sajan, T., Ehambaram, K., Gurramkonda, V. B., Ramanathan, G., & Bhaskar, L. V. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0041 · Cited by 30
“To date, most studies with TCF7L2 have genotyped either the one or two most associated SNPs reported in the original study [22], and ignored the remaining polymorphisms of the TCF7L2 gene.”
BackgroundMeta-analysis of the effect of HHEX gene polymorphism on the risk of type 2 diabetes
Cai, Y., Jiang, Y., Ma, Y., & Fu, D. (2010) · Mutagenesis · doi:10.1093/mutage/geq095 · Cited by 32
Luo, A. K., Jefferson, B. K., Garcia, M. J., Ginsburg, G. S., & Topol, E. J. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045732 · Cited by 30
A survey of allelic imbalance in F1 mice
Campbell, C. D., Kirby, A. W., Nemesh, J. C., Daly, M. J., & Hirschhorn, J. N. (2008) · Genome Research · doi:10.1101/gr.068692.107 · Cited by 34
Sequence variants affecting the genome-wide rate of germline microsatellite mutations
Kristmundsdóttir, S., Jónsson, H., Hardarson, M. T., Pálsson, G., Beyter, D., Eggertsson, H. P., Gylfason, A., Sveinbjörnsson, G., Holley, G., Stefánsson, Ó. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39547-6 · Cited by 34
Self-citationForcada, Y., Holder, A. L., Church, D. B., & Catchpole, B. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12275 · Cited by 34
Association Analyses Between Type 2 Diabetes Genes and Obesity Traits in Pigs
Du, Z., Fan, B., Zhao, X., Amoako, R., & Rothschild, M. F. (2008) · Obesity · doi:10.1038/oby.2008.557 · Cited by 34
Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
Thomas, S., Ouhtit, A., Al-Khatib, H. A., Eid, A. H., Mathew, S., Nasrallah, G. K., Emara, M. M., Maslamani, M. A. R. S. A., & Yassine, H. M. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.03.002 · Cited by 30
A neurologist’s guide to genome-wide association studies
Mullen, S. A., Crompton, D. E., Carney, P. W., Helbig, I., & Berkovic, S. F. (2009) · Neurology · doi:10.1212/01.wnl.0000341942.29513.bd · Cited by 34
Guinan, K. J. (2011) · Biochemical Genetics · doi:10.1007/s10528-011-9456-2 · Cited by 33
“…(subpopulation) Lat Long rs7903146 T (*) rs11196218 A ( ) rs12255372 T (à) rs7901695 C ( §) Size Type Source Europe Denmark 55.9 9.2 0.261 – 0.256 0.280 2,400, 2,400, 503 Control (ND) Grant et al. (2006), Helgason et al. (2007) Europe Estonia 58.7 25.7 0.203 0.271 0.193 0.242 976*à §, 974…”
InfluentialLinkage Disequilibrium Mapping of the Replicated Type 2 Diabetes Linkage Signal on Chromosome 1q
Prokopenko, I., Zeggini, E., Hanson, R. L., Mitchell, B. D., Rayner, N. W., Akan, P., Baier, L. J., Das, S. K., Elliott, K. S., Fu, M., et al. (2009) · Diabetes · doi:10.2337/db09-0081 · Cited by 32
“Although the discovery of TCF7L2 was prompted by a search for causal variants within a region of replicated type 2 diabetes linkage, neither the common variants in TCF7L2 nor those in HHEX and IDE (a second nearby GWA signal) account for that linkage signal (6).”
BackgroundThe Complex Interplay of Genetic and Lifestyle Risk Factors in Type 2 Diabetes: An Overview
Franks, P. W. (2012) · Scientifica · doi:10.6064/2012/482186 · Cited by 37
“Indeed, since the discovery ofTCF7L2 in 2006 [13],more than 100 independent genetic loci have been discovered and are now reliably associated with T2D [12] or its quantitative metabolic traits (glucose and insulin) [14].”
BackgroundGenome-wide association studies in type 1 diabetes
Grant, S. F. A., & Hakonarson, H. H. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0026-5 · Cited by 35
“Conversely, but similarly, no evidence was found for the role of the major T2D gene, TCF7L2 [ 41 ], in T1D [42,43]; although, oddly, it was shown to be strongly associated with latent autoimmune diabetes in adults [44].”
ResultSelf-citationEffects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
Bo, S., Gambino, R., Ciccone, G., Rosato, R., Milanesio, N., Villois, P., Pagano, G., Cassader, M., Gentile, L., Durazzo, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28379 · Cited by 29
Cognard, E., Dargaville, C. G., Hay, D. L., & Shepherd, P. R. (2013) · Biochemical Journal · doi:10.1042/bj20121454 · Cited by 34
Benson, K. A., Maxwell, A. P., & McKnight, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147323 · Cited by 29
“The T allele was identified as a diabetes risk factor in the pre-GWAS era and was later replicated across a number of groups with different ethnic ancestry [52,53].”
BackgroundTCF7L2 regulates pancreatic β-cell function through PI3K/AKT signal pathway
Wu, H., Li, Y.-L., Liu, N., Yang, Z., Tao, X., Du, Y., Wang, X., Lü, B., Zhang, Z., Hu, R., et al. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0449-3 · Cited by 30
Defining purpose: a key step in genetic test evaluation
Burke, W., Zimmern, R. L., & Kroese, M. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318156e45b · Cited by 29
Is FTO a type 2 diabetes susceptibility gene?
Meyre, D. (2012) · Diabetologia · doi:10.1007/s00125-012-2478-4 · Cited by 30
“Conditional overexpression of FTO in INS-1 pancreatic beta cells enhances first-phase insulin secretion in response to glucose [37], and transcription factor 7-like 2 (TCF7L2), a major determinant of type 2 diabetes risk [38], binds to the FTO promoter in this cell line [39].”
BackgroundAlSafar, H. S., Hassoun, A. A. K., Almazrouei, S., Kamal, W., Afandi, B. O., & Rais, N. (2015) · Journal of Diabetes Research · doi:10.1155/2015/129695 · Cited by 29
Zhang, Y., Meng, N., Lv, Z., Li, H., & Qu, Y. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12542 · Cited by 31
“Growing evidence suggests that the polymorphisms in the TCF7L2 gene are strongly associated with T2DM susceptibility in different populations (Damcott et al. 2006; Grant et al. 2006; Hayashi et al. 2007; Ng et al. 2007).”
BackgroundResultInfluentialBuse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 51
Li, J., Li, Z., Ouyang, X.-P., & He, P. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701279 · Cited by 36
“Among causative SNPs, rs7903146, located in exon 4 of TCF7L2, is well known for conferring a genetic predisposition to T2D (Figure 1) (9, 46).”
BackgroundReduced body weight in male Tspan8-deficient mice
Champy, M., LeVoci, L., Selloum, M., Peterson, L., Cumiskey, A.-M., & Blom, D. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.165 · Cited by 39
MicroRNA links obesity and impaired glucose metabolism
Ono, K. (2011) · Cell Research · doi:10.1038/cr.2011.78 · Cited by 29
Sjakste, T., Kalis, M., Poudziunas, I., Pīrāgs, V., Lazdins, M., Groop, L., & Sjakste, N. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2007.00372.x · Cited by 28
“…is supported by the increasing number of reports on association of different pathologies with certain intronic microsatellite alleles, including the recent finding of association of type 2 diabetes mellitus with polymorphism of an intronic microsatellite of the TCF7L2 gene (Grant et al. 2006).”
Gruber, J. D., Génissel, A., Macdonald, S. J., & Long, A. D. (2007) · Genetics · doi:10.1534/genetics.106.067108 · Cited by 30
“…al. 2006; Jeong et al. 2006; Stogmann et al. 2006; Thirumalai et al. 2006), the field has matured to the point where major discoveries are almost always documented in multiple data sets (e.g., Haines et al. 2005; Klein et al. 2005; Amundadottir et al. 2006; Graham et al. 2006; Grant et al. 2006).”
BackgroundLin, Y., Wu, C., Hsu, C., Hwang, J.-H., & Liu, T. (2011) · The Laryngoscope · doi:10.1002/lary.21771 · Cited by 28
“The gene for another transcription factor, TCF7L2 (transcription factor 7-like 2) has been recently reported as a susceptibility gene for type 2 diabetes.(26,27) Although the exact relationship between the pathophysiologic mechanisms of GRHL2 and ARHI remains unclear, it is possible that the function of GRHL2 is cruci…”
BackgroundInherited destiny? Genetics and gestational diabetes mellitus
Watanabe, R. M. (2011) · Genome Medicine · doi:10.1186/gm232 · Cited by 36
“Only three T2DM susceptibility loci had been identified before 2007: two identified by candidate gene analysis [34,35] and one by finemapping of a linkage signal [36].”
BackgroundCommon variants in TCF7L2 and CDKAL1 genes and risk of type 2 diabetes mellitus in Egyptians
El-Lebedy, D. H., & Ashmawy, I. (2016) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2016.10.004 · Cited by 31
Lu, M. H., & Li, C. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13448 · Cited by 29
Nasykhova, Y. A., Barbitoff, Y. A., Serebryakova, E. A., Katserov, D., & Glotov, A. S. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i7.376 · Cited by 35
Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome
Xu, P., Che, Y., Cao, Y., Wu, X., Sun, H., Liang, F., Sun, J., Ke, L., Yi, L., & Wang, Y. L. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9377-8 · Cited by 28
“Now it has been definitively identified as the most important T2DM susceptibility gene [5, 8].”
BackgroundUnderstanding the Genetic Basis for Adverse Drug Effects: The Calcineurin Inhibitors
Bai, J. P. F., Lesko, L. J., & Burckart, G. J. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.2.195 · Cited by 30
“7 x 10).(48) The result of TGF7L2 was replicated in all three cohorts (Iceland p=2.”
Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy
McCarthy, M. I., & Zeggini, E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.008 · Cited by 31
Patel, R. S., & Ye, S. (2011) · Heart · doi:10.1136/hrt.2010.219675 · Cited by 34
“Although sequence variations in some of such DNA elements can potentially confer susceptibility to complex diseases, they are not covered in candidate gene studies.(34)”
BackgroundYaghootkar, H., Stančáková, A., Freathy, R. M., Vangipurapu, J., Weedon, M. N., Xie, W., Wood, A. R., Ferrannini, E., Mari, A., Ring, S. M., et al. (2015) · Diabetes · doi:10.2337/db14-1456 · Cited by 28
“Similar such likely biases have been observed between strong diabetes risk alleles and BMI where the risk allele at TCF7L2 was associated with lower BMI in individuals with type 2 diabetes because individuals carrying a risk allele will develop diabetes at lower BMIs than noncarriers on average (4,11).”
TCF7L2 correlation in both insulin secretion and postprandial insulin sensitivity
Ferreira, M. C., da Silva, M. E. R., Fukui, R. T., Arruda-Marques, M. D. C., & dos Santos, R. F. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0338-1 · Cited by 27
“, liver and muscle) and resulting in insulin resistance or that the defect on insulin secretion would be exacerbated by acute free fatty acid (FFA)-induced insulin resistance [19, 21, 22].”
BackgroundSu, T., Hou, J., Liu, T., Dai, P., Qin, L., Ding, L., Hu, Y., & Guo, X. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62843 · Cited by 29
“Struan F A Grant et al.[40] reported that TCF7L2 plays an important physiological role both in pancreas and insulin sensitive organs, regulating the intestinal secretion of GLP-1 to induce β-cell proliferation[41].”
BackgroundSNP-specific extraction of haplotype-resolved targeted genomic regions
Dapprich, J., Ferriola, D., Magira, E. E., Kunkel, M. W., & Monos, D. S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn345 · Cited by 28
Bone fragility in type 2 diabetes mellitus
Yamaguchi, T. (2010) · World Journal of Orthopedics · doi:10.5312/wjo.v1.i1.3 · Cited by 30
Clinical translation of genetic predictors for type 2 diabetes
Majithia, A. R., & Florez, J. C. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283292354 · Cited by 32
Pathogenesis, Risk Assessment and Prevention of Type 2 Diabetes mellitus
Joost, H. (2008) · Obesity Facts · doi:10.1159/000137673 · Cited by 33
Surapolchai, P., Hongeng, S., Mahachoklertwattana, P., Pakakasama, S., Winaichatsak, A., Wisanuyothin, N., Pasomsub, E., Mahasirimongkol, S., & Sirachainan, N. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181dccc0b · Cited by 31
Connor, A. E., Baumgartner, R., Baumgartner, K. B., Kerber, R. A., Pinkston, C. M., John, E. M., Torres-Mejía, G., Hines, L. M., Giuliano, A. R., Wolff, R. K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2299-7 · Cited by 31
“Specific variants of TCF7L2 have been reported to be associated with risk of diabetes [2, 4, 5].”
Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes
Saxena, R., & Welt, C. K. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0383-4 · Cited by 30
Monogenic Models: What Have the Single Gene Disorders Taught Us?
Klupa, T., SKUPIEN, J. K., & Malecki, M. T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0325-0 · Cited by 34
“The only T2DM gene identified by this combined approach was TCF7L2, a transcription factor involved in the insulin secretion process [24].”
Tipping the Balance: the Pathophysiology of Obesity and Type 2 Diabetes Mellitus
McKenney, R., & Short, D. K. (2011) · Surgical Clinics of North America · doi:10.1016/j.suc.2011.08.007 · Cited by 34
Genetics of Type 2 Diabetes: the Power of Isolated Populations
Andersen, M. K., Pedersen, C. T., Moltke, I., Hansen, T. F., Albrechtsen, A., & Grarup, N. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0757-z · Cited by 38
A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Merino, J., Udler, M. S., Leong, A., & Meigs, J. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0958-0 · Cited by 35
Gupta, M. K., & Vadde, R. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.01.010 · Cited by 28
Evolution, developmental plasticity, and metabolic disease
Kuzawa, C. W., Gluckman, P. D., Hanson, M. A., & Beedle, A. S. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0019 · Cited by 30
A new era in finding Type 2 diabetes genes—the unusual suspects: RD Lawrence Lecture 2006
Frayling, T. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02172.x · Cited by 37
WNT signalling is both an inducer and effector of glucagon-like peptide-1
Gustafson, B., & Smith, U. (2008) · Diabetologia · doi:10.1007/s00125-008-1109-6 · Cited by 27
“The great interest in this topic stems from the pivotal finding by the Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe (DECODE) organisation in Iceland [2] that polymorphisms in the TCF7L2 gene, which encodes a key nuclear receptor in the WNT signalling cascade, are strongly associated w…”
BackgroundWagner, R. J., Staiger, H., Ullrich, S., Stefan, N., Fritsche, A., & Häring, H. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.001 · Cited by 27
“Previously known as a transcription factor of the WNTsignaling pathway, its link to diabetes was initially established tracing a linkage signal on chromosome 10q [23], and then replicated in a GWAS [24].”
BackgroundGenome‐wide maps of transcription regulatory elements
Sakabe, N. J., & Nóbrega, M. A. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.70 · Cited by 33
Teo, A. K. K., Gupta, M. K., Doria, A., & Kulkarni, R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.06.006 · Cited by 28
“T2D patients, characterized by early insulin resistance followed by a failure of pancreatic beta cells to compensate, develop uncontrolled hyperglycemia.”
BackgroundInfluentialTargeting Wnt signaling pathway by polyphenols: implication for aging and age-related diseases
Dana, P. M., Sadoughi, F., Mansournia, M. A., Mirzaei, H., Asemi, Z., & Yousefi, B. (2021) · Biogerontology · doi:10.1007/s10522-021-09934-x · Cited by 28
Heilmeier, U., Hackl, M., Schroeder, F., Torabi, S., Kapoor, P., Vierlinger, K., Eiríksdóttir, G., Gudmundsson, E. F., Harris, T. B., Gudnason, V. G., et al. (2022) · Bone · doi:10.1016/j.bone.2021.116308 · Cited by 28
Self-citationGenetics of murine type 2 diabetes and comorbidities
Lone, I. M., & Iraqi, F. A. (2022) · Mammalian Genome · doi:10.1007/s00335-022-09948-x · Cited by 26
Rath, P., Ranjan, A., Chauhan, A. P. S., Verma, N. K., Bhargava, A., Prasad, R., & Jindal, T. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04028-x · Cited by 27
“Another study has revealed their positive impact on TCF7L2 locus, which is a common genomic region associated with T2DM and encodes a transcription factor for proteins involved in the proper functioning of the Wnt-signalling pathway that is essential for insulin secretion and pancreatic β-cell proliferation [18, 19].”
BackgroundGong, Z., Huang, Q., Dai, X., Lei, G., Lu, H., Yin, J., Xu, X., Qu, J., Pei, Q., Dong, M., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04202.x · Cited by 26
Armenian, S. H., & Bhatia, R. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0995-8 · Cited by 27
Lomniczi, A., Garcia‐Rudaz, C., Ramakrishnan, R., Wilmot, B., Khouangsathiene, S., Ferguson, B. M., Dissen, G. A., & Ojeda, S. R. (2011) · Endocrinology · doi:10.1210/en.2011-1540 · Cited by 26
“1 and type 2 diabetes (12, 56, 57), and macular degener-”
BackgroundGenetics of type 2 diabetes and potential clinical implications
Kwak, S. H., & Park, K. S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0021-x · Cited by 27
Bone metabolism and fracture risk in type 2 diabetes mellitus
Yamaguchi, T., & Sugimoto, T. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.27 · Cited by 30
Barber, T. M., & Franks, S. (2012) · Women s Health · doi:10.2217/whe.11.94 · Cited by 36
“Variants in two genes, TCF7L2 and KCNJ11, have been demonstrated to display powerful associations with T2D [52–55] and this is likely to be mediated via impairment of insulin secretion [53,55].”
BackgroundIron deficiency modifies gene expression variation induced by augmented hypoxia sensing
Zhang, X., Zhang, W., Ma, S., Miasniakova, G., Sergueeva, A., Ammosova, T., Xu, M., Nekhai, S. A., Nourai, M., Wade, M. S., et al. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.07.016 · Cited by 28
“…SMAD2 and up-regulation of SMAD7 indicated a suppression of TGF-β signaling, which in turn was related to up-regulation of several cell proliferation suppressors, CDKN1A, E2F4 and PML , as well as up-regulation of TCF7L2 whose genetic variants associate with risk of type 2 diabetes mellitus [38].”
Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models
Kaiser, N., & Leibowitz, G. (2009) · Frontiers in bioscience · doi:10.2741/3296 · Cited by 30
“The most important T2DM susceptibility gene identified so far is transcription factor-7-like 2 (TCF7L2), which reproducibly increases the risk for T2DM in different populations (4, 72, 73).”
BackgroundGalanakis, E., Kofteridis, D. P., Stratigi, K., Petraki, E., Vazgiourakis, V., Fragouli, E., Mamoulakis, D., Boumpas, D. T., & Goulielmos, G. N. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.03.001 · Cited by 26
Lifestyle, diet, and disease: comparative perspectives on the determinants of chronic health risks
Leonard, W. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0020 · Cited by 35
Metabolic Contributions of Wnt Signaling: More Than Controlling Flight
Azar, F. A., & Lim, G. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709823 · Cited by 29
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
Ottaiano, A., Circelli, L., Santorsola, M., Savarese, G., Fontanella, D., Gigantino, V., Mauro, A. D., Capuozzo, M., Zappavigna, S., Lombardi, A., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13122 · Cited by 25
The genetics of bipolar disorder with obesity and type 2 diabetes
Miola, A., Filippis, E. D., Veldić, M., Ho, A. M., Winham, S. J., Mendoza, M., Romo‐Nava, F., Núñez, N. A., Gardea‐Resendez, M., Prieto, M. L., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.084 · Cited by 29
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.